These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9031752)

  • 1. Pharmacological characterization of the sulphonylurea receptor in rat isolated aorta.
    Löffler C; Quast U
    Br J Pharmacol; 1997 Feb; 120(3):476-80. PubMed ID: 9031752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of K(ATP) channel modulators in rat cardiac membranes.
    Löffler-Walz C; Quast U
    Br J Pharmacol; 1998 Apr; 123(7):1395-402. PubMed ID: 9579735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a specific binding site for K+ channel openers in rat aorta.
    Ouast U; Bray KM; Baumlin Y; Andres H; Manley PW
    Jpn J Pharmacol; 1992; 58 Suppl 2():226P-231P. PubMed ID: 1507537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of the K+ channel opener [3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockers.
    Quast U; Bray KM; Andres H; Manley PW; Baumlin Y; Dosogne J
    Mol Pharmacol; 1993 Mar; 43(3):474-81. PubMed ID: 8450836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional receptors in Xenopus oocytes for U-37883A, a novel ATP-sensitive K+ channel blocker: comparison with rat insulinoma cells.
    Guillemare E; Honore E; De Weille J; Fosset M; Lazdunski M; Meisheri K
    Mol Pharmacol; 1994 Jul; 46(1):139-45. PubMed ID: 8058048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding and effects of KATP channel openers in the vascular smooth muscle cell line, A10.
    Russ U; Metzger F; Kickenweiz E; Hambrock A; Krippeit-Drews P; Quast U
    Br J Pharmacol; 1997 Nov; 122(6):1119-26. PubMed ID: 9401776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulphonylurea binding in rat isolated glomeruli: pharmacological characterization and dependence on cell metabolism and cytoskeleton.
    Metzger F; Löffler C; Quast U
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):141-9. PubMed ID: 9050005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ATP-sensitive K+ channels in cardiac muscle by the sulphonylurea drug glibenclamide.
    Findlay I
    J Pharmacol Exp Ther; 1992 May; 261(2):540-5. PubMed ID: 1578371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mg2+ and ATP dependence of K(ATP) channel modulator binding to the recombinant sulphonylurea receptor, SUR2B.
    Hambrock A; Löffler-Walz C; Kurachi Y; Quast U
    Br J Pharmacol; 1998 Oct; 125(3):577-83. PubMed ID: 9806343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The vasodilator mechanism of sulfur dioxide on isolated aortic rings of rats: Involvement of the K+ and Ca2+ channels.
    Zhang Q; Meng Z
    Eur J Pharmacol; 2009 Jan; 602(1):117-23. PubMed ID: 19049805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of the actin cytoskeleton abolishes high affinity 3H-glibenclamide binding in rat aortic rings.
    Löffler-Walz C; Quast U
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):183-5. PubMed ID: 9521492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor binding characterization in kidney membrane of [3H]U-37883, a novel ATP-sensitive K+ channel blocker with diuretic/natriuretic properties.
    Meisheri K; Fosset M; Humphrey S; Lazdunski M
    Mol Pharmacol; 1995 Jan; 47(1):155-63. PubMed ID: 7838124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and solubilization of the sulphonylurea receptor in rat brain.
    Niki I; Ashcroft SJ
    Neuropharmacology; 1993 Oct; 32(10):951-7. PubMed ID: 8295717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of 3H-glibenclamide binding to sulfonylurea receptors by oral antidiabetics.
    Geisen K; Hitzel V; Okomonopoulos R; Pünter J; Weyer R; Summ HD
    Arzneimittelforschung; 1985; 35(4):707-12. PubMed ID: 3925960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleotides modulate the low affinity binding sites for [3H]glibenclamide in the rat brain.
    Zini S; Zini R; Ben-Ari Y
    J Pharmacol Exp Ther; 1993 Feb; 264(2):701-8. PubMed ID: 8437118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular interaction of sulfonylureas with beta-cell ATP-sensitive K(+)-channels.
    Kramer W; Müller G; Girbig F; Gutjahr U; Kowalewski S; Hartz D; Summ HD
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S67-80. PubMed ID: 8529521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue and species variation in the vascular receptor binding of 3H-P1075, a potent KATP opener vasodilator.
    Higdon NR; Khan SA; Buchanan LV; Meisheri KD
    J Pharmacol Exp Ther; 1997 Jan; 280(1):255-60. PubMed ID: 8996204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of sulfonylurea receptors and the action of potassium channel openers on cholinergic neurotransmission in guinea pig isolated small intestine.
    Zini S; Ben-Ari Y; Ashford ML
    J Pharmacol Exp Ther; 1991 Nov; 259(2):566-73. PubMed ID: 1658303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of MgATP on pinacidil-induced displacement of glibenclamide from the sulphonylurea receptor in a pancreatic beta-cell line and rat cerebral cortex.
    Schwanstecher M; Brandt C; Behrends S; Schaupp U; Panten U
    Br J Pharmacol; 1992 Jun; 106(2):295-301. PubMed ID: 1393263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. II. Photoaffinity labeling of a 65 kDa protein by [3H]glimepiride.
    Kramer W; Müller G; Girbig F; Gutjahr U; Kowalewski S; Hartz D; Summ HD
    Biochim Biophys Acta; 1994 May; 1191(2):278-90. PubMed ID: 8172913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.